The DCGI has said that in case of no reply, it will be presumed that the company has nothing to say in the matter and necessary action will be initiated against them...
The committee will recommend further course of action to the Drugs Controller General of India after examining and analysing the adverse event reports...
India's drug regulator Drugs Controller General of India has already initiated a probe and sought further details from the World Health Organisation...